跳至主要内容
临床试验/NCT05851911
NCT05851911招募中不适用

Children's Hospital of Chongqing Medical University

Children's Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
SARS-CoV-2 IgG

研究概览

简要总结

At present, there is no relevant research focusing on children's acquisition of novel coronavirus antibodies through maternal passive transmission. Therefore, this study assessed the changes of maternal passive transmission of COVID-19 antibodies by monitoring the specific antibodies of COVID-19 in young children; This will lay a foundation for further exploring the risk of COVID-19 infection in children and formulating immune prevention strategies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Months 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 0-2;
  • No history of blood transfusion, chemotherapy, or related immunosuppressive therapy; No immune system related diseases;

排除标准

  • Not willing to participate

结局指标

主要结局

SARS-CoV-2 IgG

时间窗: duration of time over which each participant could be 6-month to 12-month

ELISA detection of SARS-CoV-2 IgG antibody levels

SARS-CoV-2 neutralizing antibody

时间窗: duration of time over which each participant could be 6-month to 12-month

detection the level of SARS-CoV-2 neutralizing antibody

次要结局

未报告次要终点

研究者

发起方
Children's Hospital of Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

yuting yang

researcher

Children's Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验